Skip to main content
Michigan OPEN
Michigan OPEN
Resources

Exploring Long-acting Injectable Buprenorphine

This free, 1-hour CME course will equip healthcare teams with essential information on FDA-approved monthly and weekly injectable buprenorphine formulations for the treatment of OUD, along with guidance on integrating them into clinical practice.

 

 

 

 

 

 

 

Enroll in this Course!

Exploring Long-acting Injectable Buprenorphine

Meets DEA training requirements

1.0 AMA PRA Category 1 Credit(s)™

Learning objectives: 

  • Describe the different available long-acting injectable buprenorphine formulations and their dosing schedules.
  • Review current regulations related to prescribing and dispensing long-acting injectable buprenorphine.
  • Describe key considerations in determining patient eligibility for long-acting injectable buprenorphine
  • Compare the pros and cons of Sublocade and Brixadi in terms of patient selection
  • Explain the process of initiating and transitioning patients to long-acting injectable buprenorphine.

Accreditation and Credit Designation

Accreditation Council for Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Michigan OPEN. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.